HBV Genotype: A Significant Risk Factor in Determining Which Patients With Chronic HBV Infection Should Undergo Surveillance for HCC: The Hepatitis B Alaska Study,Hepatology

当前位置： X-MOL 学术 › Hepatology › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

HBV Genotype: A Significant Risk Factor in Determining Which Patients With Chronic HBV Infection Should Undergo Surveillance for HCC: The Hepatitis B Alaska Study
Hepatology ( IF 12.9 ) Pub Date : 2021-07-22 , DOI: 10.1002/hep.32065
Brian J McMahon _{1,

2,

3} , Leisha D Nolen _{2,

3} , Mary Snowball _{1,

2,

3} , Chriss Homan _{2,

3} , Susan Negus _{1,

2,

3} , Elena Roik _{2,

3} , Philip R Spradling _{2,

3} , Dana Bruden _{1,

2,

3}

Affiliation

Information is limited regarding HBV genotype and the outcome of chronic HBV (CHB) infection. We examined the effect of HBV genotype on HCC occurrence in Alaska Native (AN) persons with CHB, where five HBV genotypes are found: A2, B6, C2, D, and F1.

中文翻译：

HBV 基因型：确定哪些慢性 HBV 感染患者应接受 HCC 监测的重要风险因素：乙型肝炎阿拉斯加研究

有关 HBV 基因型和慢性 HBV (CHB) 感染结果的信息有限。我们研究了 HBV 基因型对阿拉斯加原住民 (AN) 慢性乙型肝炎患者发生 HCC 的影响，其中发现了五种 HBV 基因型：A2、B6、C2、D 和 F1。

更新日期：2021-07-22

点击分享查看原文

点击收藏

阅读更多本刊最新论文本刊介绍/投稿指南11